7Baggers
 Published on: 2025-11-18 01:26:07  newser.com Tue, 18 Nov 2025 07:26:07 GMT
 published on: 2025-11-18 00:03:52  newser.com Tue, 18 Nov 2025 06:03:52 GMT
 Published on: 2025-11-18 00:00:05  newser.com Tue, 18 Nov 2025 06:00:05 GMT
 published on: 2025-11-17 18:04:22  newser.com Tue, 18 Nov 2025 00:04:22 GMT
 published on: 2025-11-17 12:42:30  newser.com Mon, 17 Nov 2025 18:42:30 GMT
 Jefferies raises Milestone Pharmaceuticals stock price target to $2 from $1  Investing.com Nigeria Thu, 13 Nov 2025 14:20:32 GMT
 Milestone Pharmaceuticals Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:22:36 GMT
 milestone pharmaceuticals: q3 earnings snapshot  San Francisco Chronicle Wed, 12 Nov 2025 12:31:16 GMT
 Milestone Pharmaceuticals reports Q3 EPS (12c), consensus (17c)  TipRanks Wed, 12 Nov 2025 12:27:37 GMT
 Milestone Pharma Q3 net loss widens on commercial expenses  MarketScreener Wed, 12 Nov 2025 12:20:47 GMT
 Milestone Pharmaceuticals Reports Third Quarter 2025  GlobeNewswire Wed, 12 Nov 2025 12:01:52 GMT
 milestone pharmaceuticals (mist) highlights promising results fo  GuruFocus Mon, 03 Nov 2025 17:03:36 GMT

Milestone Pharmaceuticals Inc
(NASDAQ:MIST) 

MIST stock logo

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...

Full Time Employees: 28
CEO: Joseph G. Oliveto  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends